Aims: Oncogenic microRNAs (miRs) promote tumor growth and invasiveness. One of these, miR-21, contributes to carcinogenesis in prostate and other cancers. In the present study, we tested the hypothesis that NADPH oxidase-dependent reactive oxygen species (ROS) regulate the expression and function of miR-21 and its target proteins, maspin and programmed cell death 4 (PDCD4), in prostate cancer cells. Results: The highly aggressive androgen receptor negative PC-3M-MM2 prostate cancer cells demonstrated high expression of miR-21 and p47phox (an essential subunit of NADPH oxidase). Using loss-of-function strategy, we showed that transfection of PC-3M-MM2 cells with anti-miR-21- and p47phox siRNA (si-p47phox) led to reduced expression of miR-21 with concurrent increase in maspin and PDCD4, and decreased the invasiveness of the cells. Tail-vein injections of anti-miR-21- and si-p47phox-transfected PC-3M-MM2 cells in severe combined immunodeficient mice reduced lung metastases. Clinical samples from patients with advanced prostate cancer expressed high levels of miR-21 and p47phox, and low expression of maspin and PDCD4. Finally, ROS activated Akt in these cells, the inhibition of which reduced miR-21 expression. Innovation: The levels of NADPH oxidase-derived ROS are high in prostate cancer cells, which have been shown to be involved in their growth and migration. This study demonstrates that ROS produced by this pathway is essential for the expression and function of an onco-miR, miR-21, in androgen receptor-negative prostate cancer cells. Conclusion: These data demonstrate that miR-21 is an important target of ROS, which contributes to the highly invasive and metastatic phenotype of prostate cancer cells. Antioxid. Redox Signal. 19, 1863–1876.
Get full access to this article
View all access options for this article.
References
1.
AbrahamS, ZhangW, GreenbergN, ZhangM. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol, 169:1157–1161. 2003.
2.
AltekruseSF, KosaryCL, KrapchoM, NeymanN, AminouR, WaldronW, RuhlJ, HowladerN, TatalovichZ, ChoH, MariottoA, EisnerMP, LewisDR, CroninK, ChenHS, FeuerEJ, StinchcombDG. EdwardsBK. SEER Cancer Statistics Review, 1975–2007. National Cancer Institute: Bethesda, MDhttp://seer.cancer.gov/csr/1975_2007/based on November 2009 SEER data submission, posted to the SEER web site2010.
3.
American Cancer Society. Cancer Facts and Figures: Atlanta, GA, USA. American Cancer Society, 2010.
4.
AsanganiIA, RasheedSA, NikolovaDA, LeupoldJH, ColburnNH, PostS, AllgayerH. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27:2128–2136. 2008.
5.
Bhat-NakshatriP, WangG, CollinsNR, ThomsonMJ, GeistlingerTR, CarrollJS, BrownM, HammondS, SrourEF, LiuY, NakshatriH. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res, 37:4850–4861. 2009.
6.
BöhmM, SawickaK, SiebrasseJP, Brehmer-FastnachtA, PetersR, KlempnauerKH. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene, 22:4905–4910. 2003.
7.
BrarSS, CorbinZ, KennedyTP, HemendingerR, ThorntonL, BommariusB, ArnoldRS, WhortonAR, SturrockAB, HuecksteadtTP, QuinnMT, KrenitskyK, ArdieKG, LambethJD, HoidalJR. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol, 285:C353–C369. 2003.
8.
ChengY, LiuX, ZhangS, LinY, YangJ, ZhangC. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol, 47:5–14. 2009.
9.
CherML, BiliranHRJr., BhagatS, MengY, CheM, LockettJ, AbramsJ, FridmanR, ZachareasM, ShengS. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostatecancer bone metastasis. Proc Natl Acad Sci U S A, 100:7847–7852. 2003.
DelworthM, NishiokaK, PettawayC, GutmanM, KillionJ, VoneschenbachA, FidlerI. Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, a new inhibitor of s-adenosylmethionine decarboxylase, produces cytostasis of human prostate-cancer in athymic nude-mice. Int J Oncol, 6:293–299. 1995.
12.
DuJ, YangS, AnD, HuF, YuanW, ZhaiC, ZhuT. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Res, 19:487–496. 2009.
13.
FassanM, PizziM, GiacomelliL, MescoliC, LudwigK, PucciarelliS, RuggeM. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch, 458:413–419. 2011.
14.
FrankelLB, ChristoffersenNR, JacobsenA, LindowM, KroghA, LundAH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem, 283:1026–1033. 2008.
15.
FujitaS, ItoT, MizutaniT, MinoguchiS, YamamichiN, SakuraiK, IbaH. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol, 378:492–504. 2008.
JajooS, MukherjeaD, WatabeK, RamkumarV. Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia, 11:1132–1145. 2009.
18.
KumarB, KoulS, KhandrikaL, MeachamRB, KoulHK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res, 68:1777–1785. 2008.
19.
Lagos-QuintanaM, RauhutR, LendeckelW, TuschlT. Identification of novel genes coding for small expressed RNAs. Science, 294:853–858. 2001.
20.
Lankat-ButtgereitB, GökeR. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell, 101:309–317. 2009.
21.
LassègueB, ClempusRE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol, 285:R277–R297. 2003.
22.
LeeC, ShevrinDH, KozlowskiJM. In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev, 12:21–28. 1993.
23.
LiT, LiD, ShaJ, SunP, HuangY. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun, 383:280–285. 2009.
24.
LinY, LiuX, ChengY, YangJ, HuoY, ZhangC. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem, 284:7903–7913. 2009.
25.
LiuJ, YinS, ReddyN, SpencerC, ShengS. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res, 64:1703–1711. 2004.
26.
LöfflerD, Brocke-HeidrichK, PfeiferG, StocsitsC, HackermüllerJ, KretzschmarAK, BurgerR, GramatzkiM, BlumertC, BauerK, CvijicH, UllmannAK, StadlerPF, HornF. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood, 110:1330–1333. 2007.
27.
LouY, YangX, WangF, CuiZ, HuangY. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med, 26:819–827. 2010.
28.
MagentaA, CencioniC, FasanaroP, ZaccagniniG, GrecoS, Sarra-FerrarisG, AntoniniA, MartelliF, CapogrossiMC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ, 18:1628–1639. 2011.
29.
MateescuB, BatistaL, CardonM, GruossoT, de FeraudyY, MarianiO, NicolasA, MeynielJP, CottuP, Sastre-GarauX, Mechta-GrigoriouF. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med, 17:1627–1635. 2011.
30.
MeltzerPS. Cancer genomics: small RNAs with big impacts. Nature, 435:745–746. 2005.
31.
MengF, HensonR, Wehbe-JanekH, GhoshalK, JacobST, PatelT. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133:647–658. 2007.
32.
MudduluruG, MedvedF, GrobholzR, JostC, GruberA, LeupoldJH, PostS, JansenA, ColburnNH, AllgayerH. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer, 110:1697–1707. 2007.
33.
O'DonnellBV, TewDG, JonesOT, EnglandPJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J, 290:41–49. 1993.
34.
PorkkaKP, PfeifferMJ, WalteringKK, VessellaRL, TammelaTL, VisakorpiT. MicroRNA expression profiling in prostate cancer. Cancer Res, 67:6130–6135. 2007.
35.
RibasJ, NiX, HaffnerM, WentzelEA, SalmasiAH, ChowdhuryWH, KudrolliTA, YegnasubramanianS, LuoJ, RodriguezR, MendellJT, LupoldSE. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res, 69:7165–7169. 2009.
36.
SayedD, HeM, HongC, GaoS, RaneS, YangZ, AbdellatifM. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem, 285:20281–20290. 2010.
37.
SeikeM, GotoA, OkanoT, BowmanED, SchetterAJ, HorikawaI, MatheEA, JenJ, YangP, SugimuraH, GemmaA, KudohS, CroceCM, HarrisCC. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A, 106:12085–12090. 2009.
38.
SelcukluDS, DonoghueMTA, SpillaneS. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans, 37:918–925. 2009.
39.
ShengS, CareyJ, SeftorEA, DiasL, HendrixMJ, SagerR. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A, 93:11669–11674. 1996.
40.
ShethS, JajooS, KaurT, MukherjeaD, SheehanK, RybakLP, RamkumarV. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One, 7:e51655. 2012.
SiegelR, NaishadhamD, JemalA. Cancer statistics, 2012. CA Cancer J Clin, 62:10–29. 2012.
43.
SikkaSC. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention—a mechanistic approach. Curr Med Chem, 10:2679–2692. 2003.
SunXY, DonaldSP, PhangJM. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis, 22:1775–1780. 2001.
46.
TahmatzopoulosT, ShengS, KyprianouN. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene, 24:5375–5383. 2005.
47.
TalottaF, CimminoA, MatarazzoMR, CasalinoL, De VitaG, D'EspositoM, Di LauroR, VerdeP. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene, 28:73–84. 2009.
48.
ThulasingamS, MassilamanyC, GangaplaraA, DaiH, YarbaevaS, SubramaniamS, RiethovenJJ, EudyJ, LouM, ReddyJ. miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem, 352:181–188. 2011.
49.
VoliniaS, CalinGA, LiuCG, AmbsS, CimminoA, PetroccaF, VisoneR, IorioM, RoldoC, FerracinM, PrueittRL, YanaiharaN, LanzaG, ScarpaA, VecchioneA, NegriniM, HarrisCC, CroceCM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103:2257–2261. 2006.
WickramasingheNS, ManavalanTT, DoughertySM, RiggsKA, LiY, KlingeCM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res, 37:2584–2595. 2009.
52.
YangHS, ChoMH, ZakowiczH, HegamyerG, SonenbergN, ColburnNH. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol, 24:3894–3906. 2004.
53.
YangHS, JansenAP, KomarAA, ZhengX, MerrickWC, CostesS, LockettSJ, SonenbergN, ColburnNH. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol, 23:26–37. 2003.
54.
YangHS, KniesJL, StarkC, ColburnNH. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene, 22:3712–3720. 2003.
55.
YinS, LiX, MengY, FinleyRLJr., SakrW, YangH, ReddyN, ShengS. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem, 280:34985–34996. 2005.
56.
ZhangB, PanX, CobbGP, AndersonTA. microRNAs as oncogenes and tumor suppressors. Dev Biol, 302:1–12. 2007.
57.
ZhangX, NgWL, WangP, TianL, WernerE, WangH, DoetschP, WangY. MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFαCancer Res, 72:4707–4713. 2012.
58.
ZhouR, HuG, GongAY, ChenXM. Binding of NFkappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res, 38:3222–3232. 2010.
59.
ZhuS, WuH, WuF, NieD, ShengS, MoYY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 18:350–359. 2008.
60.
ZouZ, AnisowiczA, HendrixMJ, ThorA, NeveuM, ShengS, RafidiK, SeftorE, SagerR. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 263:526–529. 1994.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
